Free Trial

Prothena (PRTA) Earnings Date, Estimates & Call Transcripts

Prothena logo
$15.22 -0.79 (-4.93%)
(As of 12/20/2024 05:51 PM ET)

Prothena Latest Earnings Summary

Actual EPS
(Nov. 12)
-$1.10 Beat By $0.08
Consensus EPS
(Nov. 12)
-$1.18

Prothena posted Q3 2024 earnings on November 12, 2024, reporting an EPS of -$1.10, which beat analysts' consensus estimates of -$1.18 by $0.08. Quarterly revenue fell 98.9% year-over-year to $0.97 million, below the consensus estimate of $1.22 million. With a trailing EPS of -$2.48, Prothena's earnings are expected to decrease next year, from ($2.24) to ($4.01) per share.

Get Prothena Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Prothena and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PRTA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRTA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Prothena Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243-$1.29-$1.14-$1.20 
Q2 20243-$1.23$0.32-$0.71 
Q3 20243-$1.26-$1.17-$1.22 
Q4 20243-$1.28-$0.96-$1.16 
FY 202412-$5.06-$2.95-$4.28 
Q1 20251-$1.33-$1.33-$1.33 
Q2 20251-$1.38-$1.38-$1.38 
Q3 20251-$1.33-$1.33-$1.33 
Q4 20251$0.78$0.78$0.78 
FY 20254-$3.26-$3.26-$3.26 
Q1 20261-$1.42-$1.42-$1.42 
Q2 20261-$1.14-$1.14-$1.14 
Q3 20261-$0.20-$0.20-$0.20 

Prothena Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/12/2024Q3 2024-$1.18-$1.10+$0.08-$1.10$1.22M$0.97M
8/8/2024Q2 2024-$1.01$1.22+$2.23$1.22$10.73M$132.01M
5/8/2024Q1 2024-$1.21-$1.34 -$0.13-$1.34$3.75M$0.05M
2/15/2024Q4 2023-$1.23-$1.26 -$0.03-$1.26$2.15M$0.32M
11/2/2023Q3 2023-$0.26$0.38+$0.64$0.38$51.85M$84.87M
8/3/2023Q2 2023-$0.92-$1.03 -$0.11-$1.03$5.09M$4.02M
5/4/2023Q1 2023-$0.83-$0.89 -$0.06-$0.89$7.53M$2.17M
2/23/2023Q4 2022-$0.64$0.12+$0.76$0.12$29.14M$49.90M

Prothena Earnings - Frequently Asked Questions

Prothena (NASDAQ:PRTA) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on PRTA's earnings history.

In the previous quarter, Prothena (NASDAQ:PRTA) reported ($1.10) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.18) by $0.08. Learn more on analysts' earnings estimate vs. PRTA's actual earnings.

Prothena (NASDAQ:PRTA) has a recorded annual revenue of $133.35 million.

Prothena (NASDAQ:PRTA) has a recorded net income of -$147.03 million. PRTA has generated -$2.48 earnings per share over the last four quarters.

Prothena's earnings are expected to decrease from ($2.24) per share to ($4.01) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:PRTA) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners